Vimarsana
Biggest News Aggregation in the World

Page 2 - Between Feb News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Between Feb. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Between Feb Today - Breaking & Trending Today

Colchicine does not reduce risk of atrial fibrillation or myocardial injury after non-cardiac surgery - Vimarsana News

Colchicine does not reduce risk of atrial fibrillation or myocardial injury after non-cardiac surgery

1. Colchicine did not significantly reduce the risk of atrial fibrillation or myocardial injury after non-cardiac surgery. 2. Use of colchicine was associated with a higher incidence of non-infectious diarrhea. Evidence Rating Level: 1 (Excellent) Study Rundown: Colchicine is an anti-inflammatory drug that may be used for the management of gout and pericarditis. Patients with

Opioid analgesia may be ineffective for acute low back and neck pain - Vimarsana News

Opioid analgesia may be ineffective for acute low back and neck pain

1. Mean pain score at 6 weeks was not statistically different between the opioid and placebo groups. 2. Risk of opioid misuse after 52 weeks was higher in the opioid group compared to the placebo group. Evidence Rating Level: 1 (Excellent) Study Rundown: Opioid analgesics are commonly used for acute low back and neck pain,

Once-a-month fitusiran reduces bleeding rates in patients with hemophilia A and B with inhibitors - Vimarsana News

Once-a-month fitusiran reduces bleeding rates in patients with hemophilia A and B with inhibitors

1. Annualized bleeding rate was reduced by 91% in the fitusiran prophylaxis group compared to the bypassing agents on-demand group. 2. 5% of patients in the fitusiran group reported thromboembolic events; there were no deaths. Evidence Rating Level: 1 (Excellent) Study Rundown: Hemophilia is marked by a deficiency in certain coagulation factors that make patients

Endovascular therapy improved clinical outcomes among patients 6-24 hours post-ischemic stroke with collateral flow - Vimarsana News

Endovascular therapy improved clinical outcomes among patients 6-24 hours post-ischemic stroke with collateral flow

1. Median modified Rankin Scale score at 90 days was lower in the endovascular group, indicating improved outcomes. 2. Symptomatic intracranial bleeding was more prominent in the intervention group than control. Evidence Rating Level: 1 (Excellent) Study Rundown: Previous guidelines support the use of endovascular treatment for patients with anterior circulation artery-related ischemic stroke within

Brian Jean talks small modular reactors, hydrogen in South Korea | Grande Prairie Daily Herald Tribune - Vimarsana News

Brian Jean talks small modular reactors, hydrogen in South Korea | Grande Prairie Daily Herald Tribune

A group of oilsands companies have a committee exploring nuclear power as an alternative to burning natural gas in oilsands production.